MHRA clarifies position on off-label Avastin
Roche’s drug has been used for years to treat wet AMD, an indication for which it is not specifically licensed
Read Moreby Selina McKee | Sep 24, 2019 | News | 0
Roche’s drug has been used for years to treat wet AMD, an indication for which it is not specifically licensed
Read Moreby Selina McKee | Dec 19, 2018 | News | 0
A new report from the National Audit Office has found that In 2017-18, 42% (87 of 207) of Clinical Commissioning Groups (CCGs) were rated either ‘requires improvement’ or ‘inadequate’, with as little as 10% rated as ‘outstanding’.
Read Moreby Selina McKee | Jul 6, 2017 | News | 0
Working relationships within controversial sustainability and transformation plans (STPs) has strengthened significantly in the last five months, but NHS finance leads believe the capital being streamed into projects is simply not enough to reduce funding issues across the Service.
Read Moreby Selina McKee | Oct 5, 2016 | News | 0
The majority of clinical commissioning groups in England need to improve their cancer services to meet ambitious targets laid out by the Cancer Taskforce that are expected to save an extra 30,000 lives a year by 2020.
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
